Search by Drug Name or NDC

NDC 65086-0002-01 Omlonti 0.02 mg/mL Details

Omlonti 0.02 mg/mL

Omlonti is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Santen Incorporated. The primary component is OMIDENEPAG ISOPROPYL.

MedlinePlus Drug Summary

Omidenepag isopropyl ophthalmic is used to treat glaucoma (a condition in which increased pressure in the eye can lead to gradual loss of vision) and ocular hypertension (a condition which causes increased pressure in the eye). Omidenepag isopropyl is in a class of medications called prostaglandin agonists. It lowers pressure in the eye by increasing the flow of natural eye fluids out of the eye.

Related Packages: 65086-0002-01
Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Omidenepag Isopropyl Ophthalmic

Product Information

NDC	65086-0002
Product ID	65086-002_074cf154-7476-e203-e063-6294a90ab60e
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Omlonti
Proprietary Name Suffix	n/a
Non-Proprietary Name	omidenepag isopropyl
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	SOLUTION/ DROPS
Route	OPHTHALMIC
Active Ingredient Strength	0.02
Active Ingredient Units	mg/mL
Substance Name	OMIDENEPAG ISOPROPYL
Labeler Name	Santen Incorporated
Pharmaceutical Class	Prostaglandin E2 Receptor Agonist [EPC], Prostaglandin E2 Receptor Agonists [MoA]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA215092
Listing Certified Through	2024-12-31

Package

NDC 65086-0002-01 (65086000201)

Pricing Information	N/A
NDC Package Code	65086-002-01
Billing NDC	65086000201
Package	1 BOTTLE, PLASTIC in 1 CARTON (65086-002-01) / 2.5 mL in 1 BOTTLE, PLASTIC
Marketing Start Date	2022-09-23
NDC Exclude Flag	N